$119.96
00.00%
Last update: 4:00 PM
15 minutes delayed
Comments
Loading...
Ingredion
INGRNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Ingredion (NYSE:INGR) Stock, Analyst Ratings, Price Targets, Forecasts
Ingredion Inc has a consensus price target of $123.13 based on the ratings of 8 analysts. The high is $136 issued by UBS on November 13, 2023. The low is $110 issued by Credit Suisse on February 9, 2023. The 3 most-recent analyst ratings were released by BMO Capital, Barclays, and Goldman Sachs on May 9, 2024, March 6, 2024, and February 16, 2024, respectively. With an average price target of $125.67 between BMO Capital, Barclays, and Goldman Sachs, there's an implied 4.76% upside for Ingredion Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BMO Capital
Barclays
Goldman Sachs
Stephens & Co.
UBS
1calculated from analyst ratings
Analyst Ratings for Ingredion
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | Buy Now | 0.03% | BMO Capital | Andrew Strelzik | $117 → $120 | Maintains | Market Perform | Get Alert |
| 03/06/2024 | Buy Now | 1.7% | Barclays | Benjamin Theurer | $115 → $122 | Maintains | Equal-Weight | Get Alert |
| 02/16/2024 | Buy Now | 12.54% | Goldman Sachs | Adam Samuelson | $122 → $135 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 12.54% | Goldman Sachs | Adam Samuelson | $122 → $135 | Upgrade | Neutral → Buy | Get Alert |
| 02/07/2024 | Buy Now | 8.37% | Stephens & Co. | Ben Bienvenu | → $130 | Reiterates | Overweight → Overweight | Get Alert |
| 11/13/2023 | Buy Now | 13.37% | UBS | Cody Ross | $132 → $136 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 8.37% | Stephens & Co. | Ben Bienvenu | → $130 | Reiterates | Overweight → Overweight | Get Alert |
| 11/01/2023 | Buy Now | -8.3% | Barclays | Benjamin Theurer | $118 → $110 | Maintains | Equal-Weight | Get Alert |
| 09/29/2023 | Buy Now | 0.03% | Oppenheimer | Kristen Owen | → $120 | Initiates | → Outperform | Get Alert |
| 08/09/2023 | Buy Now | -2.47% | BMO Capital | Andrew Strelzik | $125 → $117 | Maintains | Market Perform | Get Alert |
| 08/09/2023 | Buy Now | 8.37% | Stephens & Co. | Ben Bienvenu | → $130 | Reiterates | Overweight → Overweight | Get Alert |
| 06/01/2023 | Buy Now | -1.63% | Barclays | Benjamin Theurer | $120 → $118 | Maintains | Equal-Weight | Get Alert |
| 05/04/2023 | Buy Now | 2.53% | BMO Capital | Andrew Strelzik | $115 → $123 | Maintains | Market Perform | Get Alert |
| 05/04/2023 | Buy Now | 8.37% | Stephens & Co. | Ben Bienvenu | $120 → $130 | Maintains | Overweight | Get Alert |
| 05/04/2023 | Buy Now | 0.03% | Barclays | Benjamin Theurer | $110 → $120 | Maintains | Equal-Weight | Get Alert |
| 04/14/2023 | Buy Now | -4.13% | BMO Capital | Andrew Strelzik | → $115 | Reinstates | → Market Perform | Get Alert |
| 04/13/2023 | Buy Now | 0.87% | UBS | Cody Ross | $105 → $121 | Upgrade | Neutral → Buy | Get Alert |
| 03/17/2023 | Buy Now | 0.03% | Stephens & Co. | Ben Bienvenu | → $120 | Reiterates | → Overweight | Get Alert |
| 02/09/2023 | Buy Now | -8.3% | Credit Suisse | Robert Moskow | $100 → $110 | Maintains | Neutral | Get Alert |
| 01/23/2023 | Buy Now | -8.3% | Barclays | Benjamin Theurer | → $110 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/17/2023 | Buy Now | 0.03% | Stephens & Co. | Ben Bienvenu | $100 → $120 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/07/2022 | Buy Now | -16.64% | Credit Suisse | Robert Moskow | $94 → $100 | Maintains | Neutral | Get Alert |
| 09/30/2022 | Buy Now | -25.81% | UBS | Cody Ross | → $89 | Initiates | → Neutral | Get Alert |
| 04/12/2022 | Buy Now | -21.64% | Credit Suisse | Robert Moskow | $102 → $94 | Downgrade | Outperform → Neutral | Get Alert |
| 11/09/2021 | Buy Now | -4.13% | Barclays | Benjamin Theurer | — | Initiates | → Overweight | Get Alert |
| 11/03/2021 | Buy Now | -6.64% | BMO Capital | Kenneth Zaslow | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/03/2021 | Buy Now | -8.3% | Credit Suisse | Robert Moskow | — | Upgrade | Neutral → Outperform | Get Alert |
FAQ
What is the target price for Ingredion (INGR) stock?
The latest price target for Ingredion (NYSE:INGR) was reported by BMO Capital on May 9, 2024. The analyst firm set a price target for $120.00 expecting INGR to rise to within 12 months (a possible 0.03% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ingredion (INGR)?
The latest analyst rating for Ingredion (NYSE:INGR) was provided by BMO Capital, and Ingredion maintained their market perform rating.
When was the last upgrade for Ingredion (INGR)?
The last upgrade for Ingredion Inc happened on February 15, 2024 when Goldman Sachs raised their price target to $135. Goldman Sachs previously had a neutral for Ingredion Inc.
When was the last downgrade for Ingredion (INGR)?
The last downgrade for Ingredion Inc happened on January 23, 2023 when Barclays changed their price target from N/A to $110 for Ingredion Inc.
When is the next analyst rating going to be posted or updated for Ingredion (INGR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ingredion, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ingredion was filed on May 9, 2024 so you should expect the next rating to be made available sometime around May 9, 2025.
Is the Analyst Rating Ingredion (INGR) correct?
While ratings are subjective and will change, the latest Ingredion (INGR) rating was a maintained with a price target of $117.00 to $120.00. The current price Ingredion (INGR) is trading at is $119.96, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.